Prostatic specific antigen (PSA) estimations during radiation therapy: A prognostic indicator?

Clinical Oncology ◽

10.1016/s0936-6555(05)81253-1 ◽

1991 ◽

Vol 3 ◽

pp. 298-298

Keyword(s):

Radiation Therapy ◽

Specific Antigen ◽

Prognostic Indicator ◽

Prostatic Specific Antigen

Download Full-text

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: An analysis of Radiation Therapy Oncology Group Protocol 92–02

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2006.06.017 ◽

2006 ◽

Vol 66 (4) ◽

pp. 1064-1071 ◽

Author(s):

Richard K. Valicenti ◽

Michelle DeSilvio ◽

Gerald E. Hanks ◽

Arthur Porter ◽

Harmar Brereton ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Doubling Time ◽

Radiation Therapy Oncology Group ◽

Specific Antigen ◽

Surrogate Endpoint ◽

Prostatic Specific Antigen ◽

Oncology Group ◽

Cancer Specific Survival

Download Full-text

1263: Preoperative Prostatic Specific Antigen is Correlated with Tumor Volume and Prostate Weight and Predictive of Biochemical Recurrence

The Journal of Urology ◽

10.1016/s0022-5347(18)38488-x ◽

2004 ◽

Vol 171 (4S) ◽

pp. 332-333

Author(s):

Paula J. Bunde ◽

Michael O. Koch ◽

Richard Bihrle ◽

Thomas A. Gardner ◽

John N. Eble ◽

...

Keyword(s):

Biochemical Recurrence ◽

Tumor Volume ◽

Specific Antigen ◽

Prostatic Specific Antigen ◽

Prostate Weight

Download Full-text

Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection

Minerva Urologica e Nefrologica ◽

10.23736/s0393-2249.19.03401-5 ◽

2019 ◽

Vol 71 (5) ◽

Author(s):

Antonio B. Porcaro ◽

Alessandro Tafuri ◽

Marco Sebben ◽

Tania Processali ◽

Marco Pirozzi ◽

...

Keyword(s):

Prostate Cancer ◽

Body Mass Index ◽

Radical Prostatectomy ◽

Specific Antigen ◽

Pelvic Lymph Node Dissection ◽

Prostatic Specific Antigen ◽

Node Dissection ◽

Robot Assisted ◽

Cancer Metastases

Download Full-text

Prostate-specific antigen bounce after high-dose rate interstitial radiation therapy as monotherapy for prostate cancer

Experimental and Сlinical Urology ◽

10.29188/2222-8543-2019-11-1-44-50 ◽

2019 ◽

Vol 11 (1) ◽

pp. 44-50

Author(s):

S.V. Kanaev ◽

◽

R.V. Novikov ◽

G.I. Gafton ◽

N.D. Ilyin ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Dose Rate ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

High Dose Rate ◽

High Dose ◽

Interstitial Radiation Therapy ◽

Interstitial Radiation

Download Full-text

The Role of Chromogranin A (CgA) in Monitoring Patients with Prostate Cancer Under Androgen Deprivation Therapy: Comparison with Prostatic Specific Antigen (PSA)

Current Radiopharmaceuticals ◽

10.2174/1874471010801020115 ◽

2008 ◽

Vol 1 (2) ◽

pp. 115-119

Author(s):

Athanasios Bantis ◽

Petros Sountoulides ◽

Athanasios Zissimopoulos ◽

Christos Kalaitzis ◽

Stilianos Giannakopoulos ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Chromogranin A ◽

Specific Antigen ◽

Androgen Deprivation ◽

Prostatic Specific Antigen

Download Full-text

The electrochemical immunosensor for detection of prostatic specific antigen using quince seed mucilage-GNPs-SNPs as a green composite

Bioelectrochemistry ◽

10.1016/j.bioelechem.2021.107744 ◽

2021 ◽

Vol 139 ◽

pp. 107744

Author(s):

Elahe Darvishi ◽

Hosna Ehzari ◽

Mohsen Shahlaei ◽

Leila Behbood ◽

Elham Arkan

Keyword(s):

Specific Antigen ◽

Electrochemical Immunosensor ◽

Prostatic Specific Antigen ◽

Green Composite ◽

Download Full-text

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.111 ◽

2015 ◽

Vol 93 (3) ◽

pp. S46

Author(s):

C.L. Hallemeier ◽

P. Zhang ◽

T.M. Pisansky ◽

G.E. Hanks ◽

D.G. McGowan ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Radiation Therapy ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Randomized Clinical Trials ◽

Specific Antigen ◽

Pooled Analysis ◽

Androgen Suppression

Download Full-text

Are Multiparametric Magnetic Resonance Imaging and Guided Biopsies Needed in Men with Normal Digital Rectal Examination and Prostatic-specific Antigen >20 ng/ml?

European Urology Oncology ◽

10.1016/j.euo.2021.02.004 ◽

2021 ◽

Author(s):

Juan Morote ◽

Anna Celma ◽

Jacques Planas

Keyword(s):

Magnetic Resonance Imaging ◽

Magnetic Resonance ◽

Specific Antigen ◽

Digital Rectal Examination ◽

Prostatic Specific Antigen ◽

Resonance Imaging ◽

Rectal Examination ◽

Multiparametric Magnetic Resonance Imaging

Download Full-text

A Phase I Feasibility Study of an Intraprostatic Prostate-Specific Antigen–Based Vaccine in Patients with Prostate Cancer with Local Failure After Radiation Therapy or Clinical Progression on Androgen-Deprivation Therapy in the Absence of Local Definitive Therapy

Clinical Genitourinary Cancer ◽

10.3816/cgc.2006.n.024 ◽

2006 ◽

Vol 5 (1) ◽

pp. 89-92 ◽

Author(s):

Jean-Baptiste Lattouf ◽

Philip M. Arlen ◽

Peter A. Pinto ◽

James L. Gulley

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Phase I ◽

Prostate Specific Antigen ◽

Androgen Deprivation Therapy ◽

Feasibility Study ◽

Specific Antigen ◽

Local Failure ◽

Clinical Progression ◽

Definitive Therapy

Download Full-text

The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.06.025 ◽

2021 ◽

Author(s):

Mike Wenzel ◽

Charles Dariane ◽

Fred Saad ◽

Pierre I. Karakiewicz ◽

Philipp Mandel ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Prostate Specific Antigen ◽

Biochemical Recurrence ◽

Specific Antigen ◽

Mortality Rates ◽

Localized Prostate Cancer ◽

Download Full-text